Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Department
Adjust height of sidebar
KMap
Department
College of Medicine - Tucson
59 active people
92 grants
Recent Grants
A Phase 3, Randomized, Open-label Study of MK-5684 versus Alternative Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed O
2024
·
$2.2M
prostate cancer,
clinical trial,
treatment comparison,
metastatic cancer,
hormone therapy
The Role of Receptor Dynamics in Eukaryotic Chemotaxis
2024
·
$1.6M
cell signaling,
eukaryotic biology,
biophysics,
chemotaxis,
cellular mechanisms
IGE Track 2: Graduate Communities for Academic Fellowship & Efficacy (Grad CAFE): A Holistic, Multi-tiered Mentoring Model
2024
·
$1M
academic fellowship,
efficacy,
holistic approach
Arizona Geriatrics Workforce Enhancement Program
2024
·
$991.6K
geriatrics,
workforce enhancement,
arizona,
healthcare,
elderly care
Assessing Variation in Fecal Bile Acids as a Novel Early Indicator of Necrotizing Enterocolitis
2024
·
$638.8K
gut health,
bile acids,
necrotizing enterocolitis,
early detection,
microbiome
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1)
2024
·
$277.3K
clinical trials,
autoimmune diseases,
medication efficacy,
safety assessment,
immunology
A Phase 1 Study to Evaluate the Efficacy and Safety Of AB-101, an Allogeneic Cord Blood Derived NK-Cell Therapy in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III
2024
·
$141.8K
cell therapy,
immunotherapy,
cancer treatment,
clinical trial
The Role of Na+/H+ Exchange in Shaping Gut Microbial-Epithelial Interactions and Susceptibility to Enteric Infection During Postnatal Development
2024
·
$75K
gut microbial interactions,
enteric infection,
na+/h+ exchange,
postnatal development,
epithelial interactions
Child Fatality Review Services
2024
·
$70K
public health,
child welfare,
legal system,
social services
IPA Agreement for Dr. Keith Joiner
2024
·
$49K
research collaboration,
intellectual property,
academic collaboration
Advancing Native American Physicians in Medicine Through Partnerships for Recruiting, Retaining, and Supporting Native American Students
2024
·
$40K
native american health,
medical education,
diversity in medicine,
student support,
recruitment
RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
2023
·
$1.8M
viral persistence,
immune dysregulation,
interventions evaluation,
sars-cov-2,
post-acute sequelae
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency?associated Liver Disease With Metavir
2023
·
$1.6M
clinical trial,
liver disease,
alpha-1 antitrypsin,
treatment,
safety
PARP1 and PARylation as Novel Effectors of Gut Inflammation
2023
·
$1.3M
inflammation,
parp1,
gut,
parylation,
effectors
TRANSFORM: A 52-week, Randomized, Placebo-controlled, Double-blind, Adaptive Phase 2b/3 Trial of Setanaxib with a 52-week Extension Phase in Patients with Primary Biliary Cholangitis (PBC) and Elevate
2023
·
$641.6K
clinical trial,
drug therapy,
liver disease,
biomarker,
immunology
Establishing the Function of TMEM184B in mTORC1 Regulation and Synaptic Maintenance
2023
·
$434.6K
mtorc1 regulation,
tmem184b function,
synaptic maintenance,
cellular signaling,
protein function
Use of Humanized NSG mice to optimally balance GvHD and GvL against hematologic malignancies
2023
·
$400K
immunotherapy,
cancer,
mouse models,
hematologic malignancies,
gvhd
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GLPG3667 in Adult Subject
2023
·
$138.2K
clinical trials,
pharmacology,
drug development,
safety,
efficacy
RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
2023
·
$5.5K
viral persistence,
interventions,
immune dysregulation,
post-acute sequelae,
sars-cov-2 infection
Targeting Lysosomal Vulnerabilities in Renal Pathogenesis
2022
·
$1.4M
lysosomes,
renal disease,
pathogenesis,
therapeutics,
drug discovery
People
A F M Tariqul Islam
Researcher/Scientist III
Andrew Weil
Director
Todd Boltz
Administrative Operations Manager V
Benjamin Lee
Department Chair
Carrie Foote
Administrative Operations Manager III
Baldassarre Stea
Department Head
Christine Calton
Researcher/Scientist III
Carly Deal
Clinical Research Coordinator II
Christine Butkiewicz
Data Scientist III
Claudio Bernardazzi M Azevedo
Researcher/Scientist III
Christian Twiss
Professor
David Jacobson
Financial Analyst III
Loren Drake
Research Program Administration Officer II
Edgar Garcia
Academic Programs Officer I
Gracialinda Colmenero
Administrative Strategy Professional III
Gina Schwartzberg
Research Program Administration Manager II
Dale Woolridge
Professor
Dan Davini, Jr
Laboratory Coordinator II
Grace Wagner
Academic Programs Officer III
Hien Trinh
Research Technologist III
Josie Acu?a
Associate Professor
Irshad Ali Sheikh
Researcher/Scientist III
Jenn Ronnebaum
Academic Programs Manager III
Jason Marr
Administrative Operations Manager V, Medicine
Jazmin Dagnino
Clinical Research Coordinator III
Jason Gass
Research Data Support Specialist II
Jose Munoz
Diversity and Inclusion Manager II
Christina Kalel
Academic Administrative Professional IV
Keith Joiner
Professor
Robert Kuester
Researcher/Scientist III
Mei-kuang Chen
Data Scientist IV
Kathy Smith
Professor
Lisa Higgins
Administrative Operations Manager III
Lynn Hamilton
Research Program Administration Officer IV
Lourdes Lewis
Research Technologist III
Lisa O'Neill
Health Education and Promotion Manager III
Margaret Proffitt
Student Services Administration Professional III
Alice Min Simpkins
Professor
Marc Oshiro
Researcher/Scientist III
Kevin Moynahan
Vice Dean
Monica Midura-Kiela
Laboratory Coordinator III
Maria Santa Cruz
Clinical Research Coordinator II
Tao Peng
Research Specialist, Senior
Patricia Harrison-Monroe
Psychologist IV
Paula Cook
Research Program Administration Officer IV
Patricia Lebensohn
AWCIM Educator & Curriculum Developer
Richard Amini
Professor
Rebecca Tardiff
Research Program Administration Officer III
Shona Dougherty
Professor
Stephanie Feder
Business Development Manager III
Stephen Dahmer
Director
Tarjani Thaker
Assistant Professor
Tracy Rios
Administrative Operations Manager V
Tejal Parikh
Director
Violet Siwik
Assistant Professor
David Tzou
Assistant Clinical Professor, Urology - (Clinical Series Track)
Vadim Pivniouk
Associate Research Professor
Viet Ton That
Analyst, Data II
Victoria Maizes
Founding Executive Director
Research expenses history
Funding support
9 funding agencies since 2020
